Evidence map›Paper›PMID 38276258›Full record

ArticleLife (Basel, Switzerland)2023

The Contribution of Tissue Inhibitor of Metalloproteinase-2 Genotypes to Breast Cancer Risk in Taiwan.

Yun-Chi Wang, Jie-Long He, Chung-Lin Tsai, Huey-En Tzeng, Wen-Shin Chang, Shih-Han Pan, Li-Hsiou Chen, Chen-Hsien Su, Jiunn-Cherng Lin, Chih-Chiang Hung and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Life (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Association ofIn vivo (Athens, Greece)
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Yun-Chi WangGraduate Institute of Biomedical Sciences, China Medical University, Taichung 404333, Taiwan.
Jie-Long HeDepartment of Post-Baccalaureate Veterinary Medicine, Asia University, Taichung 413305, Taiwan.
Chung-Lin TsaiDivision of Cardiac and Vascular Surgery, Cardiovascular Center, Taichung Veterans General Hospital, Taichung 407219, Taiwan.
Huey-En TzengDivision of Hematology/Medical Oncology, Department of Medicine, Taichung Veterans General Hospital, Taichung 407219, Taiwan.
Wen-Shin ChangGraduate Institute of Biomedical Sciences, China Medical University, Taichung 404333, Taiwan.
Shih-Han PanTerry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung 404327, Taiwan.
Li-Hsiou ChenGraduate Institute of Biomedical Sciences, China Medical University, Taichung 404333, Taiwan.
Chen-Hsien SuTerry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung 404327, Taiwan.
Jiunn-Cherng LinDivision of Cardiology, Department of Internal Medicine, Taichung Veterans General Hospital, Chiayi Branch, Chiayi 60090, Taiwan.
Chih-Chiang HungDivision of Breast Surgery, Department of Surgery, Taichung Veterans General Hospital, Taichung 407219, Taiwan.
Da-Tian BauGraduate Institute of Biomedical Sciences, China Medical University, Taichung 404333, Taiwan.ORCID 0000-0002-5504-8656
Chia-Wen TsaiGraduate Institute of Biomedical Sciences, China Medical University, Taichung 404333, Taiwan.
China Medical University · TWAsia University · TWTaichung Veterans General Hospital · TW

Funding

China Medical University and Asia University CMU112-ASIA-01Taichung Veterans General Hospital TCVGH-VHCY1128606
6 · The paper itself

Abstract

Tissue inhibitor of metalloproteinase-2 (TIMP-2) is an endogenous inhibitor of matrix metalloproteinase-2 and is highly expressed in breast cancer (BC) cases at diagnosis. However, the genetic investigations for the association of

Indexed as

breast cancergenotypepolymorphismtissue inhibitor of metalloproteinase-2

Identifiers

PMID38276258
PMCPMC10817502
OpenAlexW4389994716

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.